Therapeutic results in children with acute non-lymphoblastic leukemia treated with modified BFM-87 protocol]

The effectiveness of modification of the BFM-87 schedule of treatment received by 32 children with different forms of acute non-lymphoblastic leukemia since April, 1991, has been studied. Complete remission was recorded in 90% and 5-year recurrence-free survival--in 47%. Although the complication rate was higher as compared with the "7 + 3" schedule, mortality rates were relatively lower due to application of adjuvant therapy.